pyrilamine has been researched along with neuropeptide y in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (71.43) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Altenbach, RJ; Brioni, JD; Carr, TL; Chandran, P; Cowart, MD; Esbenshade, TA; Honore, P; Hsieh, GC; Lewis, LG; Liu, H; Manelli, AM; Marsh, KC; Milicic, I; Miller, TR; Strakhova, MI; Vortherms, TA; Wakefield, BD; Wetter, JM; Witte, DG | 1 |
| Grundemar, L; Håkanson, R; Shen, GH; Wahlestedt, C; Zukowska-Grojec, Z | 2 |
| Nurko, S; Rattan, S | 1 |
| Edvinsson, L; Hedner, T; Sun, X | 1 |
| Hirabayashi, A; Ishikawa, N; Nishiwaki, K; Shimada, Y | 1 |
| Higuchi, H; Nagai, S; Niki, T; Piao, H; Tsurumaki, T | 1 |
7 other study(ies) available for pyrilamine and neuropeptide y
| Article | Year |
|---|---|
cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzofurans; Carrageenan; Disease Models, Animal; Drug Design; Drug Evaluation, Preclinical; Humans; Hyperalgesia; Ligands; Mice; Molecular Structure; Pain; Peritonitis; Quinazolines; Rats; Receptors, G-Protein-Coupled; Receptors, Histamine; Receptors, Histamine H4; Stereoisomerism; Structure-Activity Relationship | 2008 |
C-terminal neuropeptide Y fragments are mast cell-dependent vasodepressor agents.
Topics: Animals; Aorta; Binding, Competitive; Blood Pressure; Cells, Cultured; Consciousness; Decerebrate State; Heart Rate; Histamine Release; Kinetics; Male; Mast Cells; Muscle, Smooth, Vascular; Neuropeptide Y; Peptide Fragments; Peptide YY; Peptides; Pyrilamine; Rats; Rats, Inbred Strains; Receptors, Neuropeptide Y; Receptors, Neurotransmitter; Structure-Activity Relationship | 1991 |
Role of neuropeptide Y in opossum internal anal sphincter.
Topics: Anal Canal; Animals; Atropine; Dose-Response Relationship, Drug; Electric Stimulation; Guanethidine; Indomethacin; Lumbosacral Plexus; Methysergide; Muscle Contraction; Muscle, Smooth; Naloxone; Neuropeptide Y; Opossums; Pyrilamine; Rectum; Reference Values; Tetrodotoxin | 1990 |
Biphasic blood pressure response to neuropeptide Y in anesthetized rats.
Topics: Anesthesia; Animals; Blood Pressure; Decerebrate State; Heart Rate; Injections, Intravenous; Male; Neuropeptide Y; Pyrilamine; Rats; Rats, Inbred Strains | 1990 |
Histamine-independent modulation of the neuropeptide Y-induced pressor response by alpha-trinositol in the pithed rat.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Cimetidine; Decerebrate State; Diphenhydramine; Electric Stimulation; Heart Rate; Histamine Antagonists; Injections, Intravenous; Inositol Phosphates; Male; Neuropeptide Y; Phenylephrine; Pyrilamine; Rats; Rats, Sprague-Dawley; Vasopressins | 1994 |
Role of neuropeptide Y and its receptor subtypes in neurogenic pulmonary edema.
Topics: Animals; Capillary Permeability; Carbon; Male; Neuropeptide Y; Norepinephrine; Propranolol; Pulmonary Edema; Pyrilamine; Rats; Rats, Wistar; Receptors, Neuropeptide Y | 1996 |
Potentiation by neuropeptide Y of histamine H1 receptor-mediated contraction in rat blood vessels.
Topics: Animals; Arteries; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Histamine; Histamine H1 Antagonists; In Vitro Techniques; Male; Neomycin; Neuropeptide Y; Phenylcarbamates; Pyrilamine; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Receptors, Histamine H1; Receptors, Neuropeptide; RNA, Messenger; Type C Phospholipases; Vasoconstriction; Vasoconstrictor Agents; Veins | 2007 |